Weight Loss

Peptide stacking has gained attention among people looking for new ways to support fat reduction. In medical settings, stacking refers to combining compounds that influence different hunger, metabolic, or recovery pathways. When done under the guidance of a licensed provider, a stack can be designed around medications with reliable clinical data—most commonly GLP-1 therapies such as semaglutide or tirzepatide. Vigor Compounding can play a […]

Many people considering semaglutide for weight loss worry about side effects, and one of the most common questions is whether it can cause hair loss. While the GLP-1 medication itself is not believed to directly cause hair loss, the rapid weight loss it helps induce can sometimes trigger a temporary condition known as telogen effluvium. This condition causes hair follicles to

Have you ever considered trying weight loss injections but hesitated, fearing judgment or the perception that you’re taking the “easy way out”? You’re not alone. Despite their proven effectiveness, brand-name treatments — as well as compounded GLP-1 medications — often carry an unfair stigma. At Vigor Compounding, our specialized GLP-1 injections include a unique vitamin B6

Starting or maintaining a successful weight loss practice isn’t just about prescribing medication—it’s about fostering lasting change. Patients struggling with weight management often face emotional and psychological hurdles that make the journey challenging. Generally, individuals who receive structured support are more likely to maintain weight loss compared to those who go it alone. So, how can healthcare providers build a

GLP-1 medications have revolutionized weight loss, helping countless people shed pounds effectively. If you’re considering weight loss injections, understanding the key differences between compounded and brand-name GLP-1s can help you make an informed decision. Below, we break down what sets them apart and why compounded GLP-1s from Vigor Compounding are gaining popularity. Our cutting-edge GLP-1 medications are compounded with

Over 41% of U.S. adults are classified as obese, according to the CDC. Many of these people are actively seeking medically supervised weight loss solutions, which has created an incredible opportunity for healthcare providers. GLP-1 receptor agonists like Semaglutide andTirzepatide are revolutionizing weight management by offering real results and helping medical practices thrive. If you’re a healthcare provider looking to